| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,197 |
1,168 |
$222K |
| J2406 |
Injection, oritavancin (kimyrsa), 10 mg |
56 |
37 |
$182K |
| 99233 |
Prolong inpt eval add15 m |
2,604 |
931 |
$153K |
| 99223 |
Prolong inpt eval add15 m |
1,239 |
1,190 |
$125K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,054 |
844 |
$62K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
35 |
35 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
234 |
219 |
$10K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
12 |
12 |
$3K |